24.05

3.74% -0.9624

Beam Therapeutics Inc (BEAM)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BEAM? Forum Prognose

Schlusskurs vom Vortag:

$25.01

Offen:

$24.67

24-Stunden-Volumen:

297.95K

Relative Volume:

0.11

Marktkapitalisierung:

$2.43B

Einnahmen:

$352.57M

Nettoeinkommen (Verlust:

$-143.01M

KGV:

-13.29

EPS:

-1.81

Netto-Cashflow:

$-153.40M

1W Leistung:

-9.93%

1M Leistung:

-6.50%

6M Leistung:

+18.95%

1J Leistung:

+4.99%

1-Tages-Spanne:

$23.94

$25.19

1-Wochen-Bereich:

$23.50

$26.67

52-Wochen-Spanne:

$13.53

$35.25

Beam Therapeutics Inc Stock (BEAM) Company Profile

Firmenname

Beam Therapeutics Inc

Sektor

Healthcare (1137)

Branche

Biotechnology (635)

Telefon

857-327-8775

Adresse

26 LANDSDOWNE STREET, CAMBRIDGE, MA

Mitarbeiter

509

Twitter

Nächster Verdiensttermin

2024-11-05

Neueste SEC-Einreichungen

BEAM's Discussions on Twitter

Vergleichen Sie BEAM mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BEAM Beam Therapeutics Inc	24.01	2.53B	352.57M	-143.01M	-153.40M	-1.81
VRTX Vertex Pharmaceuticals Inc	423.74	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	640.57	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	444.54	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	824.40	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	183.00	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Beam Therapeutics Inc Stock (BEAM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-09	Eingeleitet	Jefferies	Buy
2025-03-28	Hochstufung	BofA Securities	Neutral → Buy
2025-03-10	Hochstufung	Scotiabank	Sector Perform → Sector Outperform
2025-01-29	Hochstufung	Cantor Fitzgerald	Neutral → Overweight
2024-11-06	Hochstufung	Leerink Partners	Market Perform → Outperform
2024-10-16	Eingeleitet	Scotiabank	Sector Outperform
2024-07-23	Eingeleitet	H.C. Wainwright	Buy
2024-01-29	Hochstufung	JP Morgan	Neutral → Overweight
2023-12-15	Herabstufung	BofA Securities	Buy → Neutral
2023-12-08	Herabstufung	Jefferies	Buy → Hold
2023-10-20	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2023-10-20	Herabstufung	Leerink Partners	Outperform → Market Perform
2023-03-21	Eingeleitet	Bernstein	Mkt Perform
2023-02-01	Eingeleitet	Cantor Fitzgerald	Overweight
2022-12-20	Hochstufung	BMO Capital Markets	Market Perform → Outperform
2022-12-13	Eingeleitet	Citigroup	Buy
2022-06-17	Eingeleitet	BMO Capital Markets	Market Perform
2022-04-28	Eingeleitet	Credit Suisse	Neutral
2022-01-05	Eingeleitet	Guggenheim	Buy
2021-10-19	Eingeleitet	SVB Leerink	Outperform
2021-09-24	Fortgesetzt	Stifel	Buy
2021-09-10	Eingeleitet	BofA Securities	Buy
2021-05-11	Eingeleitet	Redburn	Buy
2021-05-04	Eingeleitet	RBC Capital Mkts	Sector Perform
2021-03-01	Herabstufung	Barclays	Overweight → Equal Weight
2021-02-16	Eingeleitet	Wells Fargo	Overweight
2021-01-29	Herabstufung	JP Morgan	Overweight → Neutral
2021-01-06	Eingeleitet	Stifel	Hold
2020-08-05	Eingeleitet	William Blair	Outperform
2020-03-02	Eingeleitet	Barclays	Overweight
2020-03-02	Eingeleitet	JP Morgan	Overweight
2020-03-02	Eingeleitet	Jefferies	Buy
2020-03-02	Eingeleitet	Wedbush	Outperform

Alle ansehen

Beam Therapeutics Inc Aktie (BEAM) Neueste Nachrichten

09:35 AM

Beam to present updated data on sickle cell gene therapy at ASH meeting - Investing.com

09:35 AM

09:00 AM

ASH 2025: Beam Therapeutics (NASDAQ: BEAM) to share updated BEAM-101 sickle cell data - Stock Titan

09:00 AM

06:23 AM

Why retail investors favor Beam Therapeutics Inc. stockTrade Performance Summary & Long-Term Capital Growth Ideas - newser.com

06:23 AM

05:41 AM

AMG National Trust Bank Buys Shares of 17,007 Beam Therapeutics Inc. $BEAM - MarketBeat

05:41 AM

03:22 AM

How Beam Therapeutics Inc. stock compares to market leaders2025 Market Overview & Accurate Buy Signal Alerts - newser.com

03:22 AM

02:25 AM

How buybacks impact Beam Therapeutics Inc. stock value2025 Trade Ideas & Technical Buy Zone Confirmations - newser.com

02:25 AM

Nov 02, 2025

Institutional scanner results for Beam Therapeutics Inc.Weekly Volume Report & Entry and Exit Point Strategies - newser.com

Nov 02, 2025

Real time social sentiment graph for Beam Therapeutics Inc.2025 Market Overview & Expert Curated Trade Ideas - newser.com

Nov 02, 2025

How to monitor Beam Therapeutics Inc. with trend dashboardsStop Loss & High Accuracy Trade Signal Alerts - newser.com

Nov 02, 2025

Published on: 2025-11-02 01:58:11 - newser.com

Nov 02, 2025

Nov 01, 2025

Why Beam Therapeutics Inc. stock is favored by pension fundsQuarterly Performance Summary & Fast Moving Market Watchlists - newser.com

Nov 01, 2025

Will Beam Therapeutics Inc. stock deliver long term returnsPortfolio Profit Report & Weekly Top Performers Watchlists - newser.com

Nov 01, 2025

Should you wait for a breakout in Beam Therapeutics Inc.Sell Signal & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 01, 2025

Oct 31, 2025

Will Beam Therapeutics Inc. stock outperform Nasdaq indexInsider Buying & Stepwise Trade Signal Guides - newser.com

Oct 31, 2025

What hedge fund activity signals for Beam Therapeutics Inc. stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com

Oct 31, 2025

Published on: 2025-10-31 03:50:40 - newser.com

Oct 31, 2025

Visualizing Beam Therapeutics Inc. stock with heatmaps2025 Institutional Moves & Daily Chart Pattern Signals - newser.com

Oct 31, 2025

ETFs Investing in Beam Therapeutics Inc. Stocks - TradingView

Oct 31, 2025

Why retail investors pile into Beam Therapeutics Inc. stockTreasury Yields & Real-Time Volume Triggers - newser.com

Oct 31, 2025

Oct 30, 2025